Nasmed Ozel Saglik Hizmetleri Ticaret AS (EGEPO) - Total Liabilities

Latest as of December 2024: TL303.09 Million TRY ≈ $6.79 Million USD

Based on the latest financial reports, Nasmed Ozel Saglik Hizmetleri Ticaret AS (EGEPO) has total liabilities worth TL303.09 Million TRY (≈ $6.79 Million USD) as of December 2024. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check EGEPO cash and liquid asset ratio to evaluate the company's liquid asset resilience ratio.

Nasmed Ozel Saglik Hizmetleri Ticaret AS - Total Liabilities Trend (2019–2024)

This chart illustrates how Nasmed Ozel Saglik Hizmetleri Ticaret AS's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see total assets of Nasmed Ozel Saglik Hizmetleri Ticaret AS.

Nasmed Ozel Saglik Hizmetleri Ticaret AS Competitors by Total Liabilities

The table below lists competitors of Nasmed Ozel Saglik Hizmetleri Ticaret AS ranked by their total liabilities.

Company Country Total Liabilities
Pieridae Energy Ltd
TO:PEA
Canada CA$438.42 Million
KKB Engineering Berhad
KLSE:9466
Malaysia RM209.50 Million
AurosTechnology Inc.
KQ:322310
Korea ₩58.38 Billion
Senkron Guvenlik ve Iletisim Sistemleri AS
IS:SNKRN
Turkey TL44.19 Million
Island Pharmaceuticals Ltd
AU:ILA
Australia AU$336.43K
Smart Gunes Enerjisi Teknolojileri Arastirma Gelistirme Uretim Sanayi ve Ticaret
IS:SMRTG
Turkey TL18.13 Billion
SNC Former Public Company Limited
BK:SNC
Thailand ฿7.16 Billion
West Vault Mining
V:WVM
Canada CA$14.32 Million

Liability Composition Analysis (2019–2024)

This chart breaks down Nasmed Ozel Saglik Hizmetleri Ticaret AS's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See EGEPO net asset quality score to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 1.64 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.22 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.18 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Nasmed Ozel Saglik Hizmetleri Ticaret AS's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Nasmed Ozel Saglik Hizmetleri Ticaret AS (2019–2024)

The table below shows the annual total liabilities of Nasmed Ozel Saglik Hizmetleri Ticaret AS from 2019 to 2024.

Year Total Liabilities Change
2024-12-31 TL303.09 Million
≈ $6.79 Million
-26.08%
2023-12-31 TL410.01 Million
≈ $9.18 Million
+128.87%
2022-12-31 TL179.14 Million
≈ $4.01 Million
+83.27%
2021-12-31 TL97.75 Million
≈ $2.19 Million
+10.05%
2020-12-31 TL88.82 Million
≈ $1.99 Million
+31.57%
2019-12-31 TL67.51 Million
≈ $1.51 Million
--

About Nasmed Ozel Saglik Hizmetleri Ticaret AS

IS:EGEPO Turkey Medical Care Facilities
Market Cap
$81.86 Million
TL3.65 Billion TRY
Market Cap Rank
#20081 Global
#263 in Turkey
Share Price
TL7.31
Change (1 day)
-7.12%
52-Week Range
TL6.98 - TL19.92
All Time High
TL32.10
About

Nasmed Özel Saglik Hizmetleri Ticaret Anonim Sirketi provides healthcare services in Turkey. The company's medical units include oral and dental health; anesthesiology and reanimation; nutrition and diet; brain and nerve surgery; childhood diseases; dermatology; endocrinology and metabolic diseases; infectious diseases and clinical microbiology; aesthetic, plastic, and reconstructive surgery; hom… Read more